Mr. Morgan's practice focuses on all areas of intellectual property law including patent prosecution both in the U.S. and abroad, patent litigation and opinion work.

Mr. Morgan has experience preparing and prosecuting patent applications in the chemical and mechanical arts. His practice also encompasses client counseling, including the preparation of right-to-use/clearance, invalidity and patentability opinions.

Mr. Morgan is experienced in all stages of litigation, including evaluating infringement and invalidity positions, handling discovery, preparing for summary judgment and drafting pre-trial and trial motions. He has been involved in litigations covering a wide range of technology including pharmaceuticals (initiated under the Hatch Waxman Act), medical devices and various consumer products.

• Publications Editor, University of Cincinnati Law Review, University of Cincinnati College of Law
• Dean's List, 5 of 6 semesters, University of Cincinnati College of Law
• Wood Scholarship Recipient, University of Cincinnati College of Law
• Vice President, Black Law Students Association, University of Cincinnati College of Law
• Tau Beta Pi, Engineering Honor Society

• Kannar v. Alticor Inc., et al. 09-CV-2500 (C.D. Cal., filed December 2008). Representing defendants in a patent infringement suit.
• Abbott Labs. v. Sandoz Inc., 07-1400 (Fed. Cir. May 18, 2009) (en banc). Successfully represented Sandoz Inc. in an appeal before the U.S. Court of Appeals for the Federal Circuit dealing with claim construction and the proper interpretation of product-by-process claims. In a landmark decision, the Federal Circuit affirmed the district court's claim construction, and the en banc Court resolved the long-standing conflict on the interpretation of product-by-process claims between its prior decisions in Atlantic Thermoplastics and Scripps Clinic. Following Supreme Court precedent, the Court upheld the rule in Atlantic Thermoplastics that product-by-process claims are limited by their process steps.
• Abbott Labs. v. Sandoz Inc., 486 F. Supp. 2d 767 (N.D. Ill. 2007). Successfully defended Sandoz Inc. against request for temporary restraining order and preliminary injunction by Abbott and Astellas before Judge Wayne R. Andersen over patents relating to a polymorph of crystalline cefdinir, an antibiotic also sold as Omnicef^®.
• Anchor Sports I, Inc. v. Schutt Sports, Inc. (E.D. Tex. 2007). This case, and a companion ITC action, involved a patent related to molded plastic parts. Case settled after Markman positions were exchanged.
• One World Technologies, Ltd. v. Rexon Industrial Corp., Ltd., et al., No. 04 C 4337 (N.D. Ill., Nov. 2006). Subject: Infringement of our clients' patents relating to a miter saw having a laser arbor and to a portable power tool support assembly. Resolution: Case resolved by a confidential settlement agreement.

• "The Supreme Court Rules on Bilski v. Kappos, No. 08-964," Client Alert, June 29, 2010
• "Biosimilar Provisions Enacted In Health Care Bill," Client Alert, March 26, 2010

• "CAFC and Supreme Court Watch: Three Cases that May Have Radical Impact on Pharmaceutical Patent Life Cycle Strategies," ACI's 12th Annual Maximizing Pharmaceutical Patent Life Cycles, New York City, October 4, 2011

• American Bar Association
• National Bar Association
• Chicago Bar Association
• Chicago Committee on Minorities in Large Law Firms, Associate Board

• The Supreme Court Rules on Bilski v. Kappos, No. 08-964
• Biosimilar Provisions Enacted in Health Care Bill

• Brinks Hofer Gilson & Lione Hosts Chicago High School Students from Just the Beginning Foundation's 2008 Summer Legal Institute
• Twelve New Associates, Scientific Advisor Join Brinks Hofer Gilson & Lione
• Brinks Hofer Gilson & Lione Hosts Grand Send-Off for 2005 Summer Associates

• IP Law & Business
• Minority Law Journal
• Young Black Professional Guide
• ChicagoLawyer.com